Feature: The Boston Ibogaine Forum -- from Shamanism to Cutting Edge Science

special to Drug War Chronicle by Doug Greene, assisted by Kevin Franciotti

On a cold and clear Presidents Day weekend, dozens of treatment professionals, underground providers, patients, researchers and entheogenic enthusiasts gathered at Boston's Northeastern University for the Boston Ibogaine Forum, the 2009 installment of the annual ibogaine conference, sponsored the Northeastern Students for Sensible Drug Policy (which is also hosting the Northeast SSDP Regional conference on April 3-5), the National AIDS Brigade, and Cures Not Wars.

conference panel, Dana Beal at podium
Ibogaine is considered the 'active' compound in the Tabernanthe iboga plant, used for centuries as a healer, teacher, and catalyst for ceremonies by the Bwiti people indigenous to what is now the Central-west African republic of Gabon. But the versatile plant has remained virtually unknown in the West, where it has a very different history.

Researcher Howard Lotsof, PhD, addicted to heroin and methadone, discovered the anti-addictive action of ibogaine in 1962. Given a capsule of pure ibogaine HCL by a trusted friend who was familiar with chemistry, Lotsof was simply seeking a new high. He was astonished when coming out of this difficult experience 36-opiate-abstinent hours later to realize he had no physical craving for opiates, and even more remarkably, had experienced very little of the agonizing physical symptoms normally associated with opiate withdrawal.

Although other early research was undertaken in the 1960s, ibogaine's eventual acceptance as anti-addiction agent in the West was tied to Lotsof's remarkable personal story. Off opiates, Lotsof turned with enthusiasm toward ibogaine and other psychedelics, running trials in the mid-1960s before going to prison under new federal drug laws banning the psychedelics at the end of the decade. For another two decades, Lotsof and ibogaine as addiction treatment wandered in the wilderness, his research supported by groups such as Cures Not Wars.

It was only in 1989 that Lotsof made significant contacts with mainstream researchers, who undertook their own pioneering researches. In the years between then and now, thanks to the missionary efforts of Lotsof and his supporters, ibogaine has ever so slowly become of greater and greater interest to addiction researchers and others.

Valentine's Day morning found ibogaine aficionados at the movies for Facing the Habit, a 2007 film featuring heroin users who succeed -- or fail -- to kick their habit through ibogaine treatments. Next up was ibogaine's most prominent advocate, the mustachioed Cures not Wars co-founder and Yippie! Dana Beal, who brought conference attendees up to speed on the latest research on ibogaine's anti-addictive properties, including its ability to regenerate dopamine pathways in the brain through its activation of glial cell line-derived neurotrophic factor GDNF. This exciting research had a panel of its own later in the day featuring Roman Paskulin, founder and director of Slovenia's Open Mind Institute and Dr. Tracy Blevins.

Beal was followed by a panel of ibogaine treatment providers discussing the special safety challenges involved in treating multiple addictions to different drugs, including Drs. Anwar Jeewa and A.R. Gani, of the groundbreaking residential treatment center Minds Alive in Durban, South Africa, Dr. Bruno Rasmussin of Brazil, and long-time provider Rocky Caravelli.

Next up was one of the most interesting presentations of the conference, by Justin Kirkland, Vice President of Sales and Marketing for Obiter Research on the company's efforts to develop more cost-effective methods of synthesizing 18 Methoxycorinaridine 18-MC, an ibogaine analog with fewer side effects and greater potential for treating methamphetamine and nicotine dependence. The day's events closed with McLean Hospital's Dr. Carl Anderson discussing ibogaine, dream states and fetal R.E.M.

Sunday started with another ibogaine documentary, the Dutch Rites of Passage, followed by SSDP Northeastern's Arielle Torra presenting on the subjective experiences of patients treated at Dr. Deborah Mash's Healing Transitions Institute for Addiction clinic on St. Kitts.

The first scheduled panel of the day addressed the controversial use of ibogaine for other indications, including hepatitis C (HCV). Former New Mexico Department of Health Harm Reduction Coordinator Phillip Fiuty and Rocky Caravelli confirmed the existence of HCV patients whose conditions have improved and even cleared the virus without interferon treatment. Caravelli also described positive effects on herpes, MS and asthma. Jason Farrell, founder and former executive director of Positive Health Project and currently CEO of Harm Reduction Consulting Services, Inc., suggested a collaborative study by clinics in South Africa, Mexico and Brazil tracking the viral loads of HIV/HCV patients for six months to a year.

Next, former High Times and drugwar.com writer and editor Preston Peet gave dramatic personal testimony on ibogaine's efficacy in managing chronic pain by drastically cutting opioid tolerance.

The liveliest panel of the conference came up next, featuring Patrick Kroupa -- a pioneer hacker and long-time activist whose multiple roles include High Priest of the Sacrament of Transition, an Eastern European based iboga religion -- Dr. Deborah Mash, Peet, and Lenny of the New York City ibogaine support group comparing ibogaine to more conventional treatments, such as 12-step cold turkey, methadone taper, buprenorphine and ultra-rapid opiate detox (UROD). UROD -- the direct injection of the opiate blocker naltrexone under benzodiazepine sedation -- was denounced by all panelists as ineffective and inhumane.

The next panel, comparing the anti-addictive effects of ibogaine to other entheogens, featured Harvard Assistant Professor of Psychiatry John H. Halpern and Jon Harrison, the principal investigator for the Multidisciplinary Association for Psychedelic Studies ibogaine outcome study at Pangea Biomedics in Playas de Tijuana, Mexico. Halpern compared ibogaine's effectiveness to other entheogens sometimes given as treatment modalities for drug addiction, most notably peyote use in the possible treatment of alcoholism among the Native American population, and the sacramental use of ayahuasca among American members of the Santo Daime and UDV churches.

This observational case study is examining changes in substance use in 30 individuals seeking ibogaine-based addiction treatment, and is intended to gather information to evaluate whether ibogaine-assisted therapy helps opiate-dependent people stop using opiates or practice moderated use after the therapy. Twelve-month follow-up data is being collected from participants in the study to examine whether ibogaine-assisted therapy facilitates improvements in quality of life that result in decreased harms associated with chronic or mismanaged opiate use. The study has received Institutional Review Board approval from the California Institute of Integral Studies and has enrolled 11 of the 30 subjects. For many months, MAPS had no success in raising funds for the study, but received its first significant donation at the conference, and by March 2nd, had raised all the funds for the study.

Halpern, who's published some of the only research on peyote use by Native Americans, surprised the crowd by revealing that the National Institute on Drug Abuse had so constrained his research that he wasn't allowed to directly study peyote's manifest anti-addictive effects. He also had no data on receptor-mediated anti-addictive effects, ascribing it all to "psychedelic glow."

Sunday's program closed with Makky, Boston University Professor of Classical Studies Carl Ruck and Beal discussing shamanic scenes in South America vs. Africa, a possible iboga role in the ancient world, and the dangers of "The Mushroom and the Cross" approach offending fundamentalists, respectively.

Presidents Day opened with a roundup of the international ibogaine scene. Venezuelan Drs. Rosaria Dávalos and Zulema Medrano described great progress in promoting ibogaine treatments, but also obstacles due to continued deference to the US. Drs. Jeewa and Gani gave details on their residential treatment center. Australian treatment provider Jason Chamon described a smaller, informal treatment scene -- clandestine in Australia, legal in New Zealand. De Loenen finished up, appearing live via Skype to contrast the more relaxed attitudes in Spain and Portugal with a forum in Holland on arrhythmia in ibogaine patients.

The international ibogainesters were followed by a panel on ibogaine's role in harm reduction, featuring Jason Farrell, Phil Fiuty and Cures not Wars cofounder and veteran drug policy activist Doug Greene. Farrell stressed the need for ibogaine treatment providers to be careful about whom they treat to minimize risks, citing a recent case in Netherlands where a patient refused to stop alcohol use before a treatment and had a seizure and then two days of arrythmia. At the same time, he urged greater availability of ibogaine treatment, advising potential providers to get a space and cots and "just do it." Greene praised ibogaine as the most libertarian option for drug treatment, and called on the drug policy reform movement to center its efforts on marijuana and ibogaine.

The conference closed with a panel that included the National AIDS Brigade's Jon Stuen-Parker discussing his lawsuit against the federal government for inattention to crack and heroin. MAPS founder and President Rick Doblin then gave the attendees a road map to promote ibogaine to state and federal policymakers, while Dana Beal suggested a letter from members of Congress to President Obama's forthcoming DEA Administrator.

This was the first ibogaine conference to be streamed live on the Internet, with twice as many people often logged-on as were in the room. Although speakers and attendees alike were frustrated by the conference's uneven pacing and complete disregard of the announced, reaction to the content of the conference was generally positive. Jason Farrell said: "It was a very impressive conference that opened my eyes to the serious, international work that's being done on ibogaine. It's unfortunate that it didn't get the news coverage it deserved."

Long-time drug policy reform activist Valerie Vande Panne said: "It's good to see ibogaine getting the research and recognition it deserves. Clearly, it has been beneficial in a holistic, dignified, and humane way to the lives of many who considered themselves addicts ready for a life change."

Rick Doblin said: "Many of the speakers were fascinating and had lots of experience and important information to share, and the future of ibogaine is bright. The clinics are moving toward more of an above-ground, responsible medical model and are realizing the importance of aftercare programs. I'm not sure where resources would come from for clinical studies to make ibogaine legal in the US -- that may be a stretch too far for NIDA, even under Obama. While I don't see commercial drug development happening in the near term in the US, or anywhere else, there will be more prospective research at the clinics which will, over time, build support for more clinical studies."

Streaming video of the conference can be found here.

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.
Looking for the easiest way to join the anti-drug war movement? You've found it!

Thank you for writing about the Ibogaine forum in Boston

I am not an addict but someone who loves an addict. I have been doing my own resurch on the internet for the recovery of heroin and stumbled upon Ibogaine over a year ago. Reading everything I could find from Dr. Mash, to Youtube and anyone that had an opinion on Ibogaine. I recieve daily alerts on my email for ibogaine and this how I educated myself. When I recieved the forum notice on Ibogaine for Boston I contacted Dana right away, I was so pleased to meet many of the people that I could only read about on the internet. I was at the forum Saturday and Monay eveyone was just wonderful to me answering my many question. I try to always spread the word about ibogaine and educate those that are interested. I brought the person that I care about and his family they too were very pleased with forum.

I just want to thank Doug Green for writing about the forum and hope that many read about Ibogaine and understand that heroin and other drugs are every where and addiction is hard not just on the individual but the people that love and care about them. Ibogaine is not a cure but a second chance.
If it were not for the cost of travel, and the current cost of Ibogaine we would be on the next plane to see Rocky or many of the other programs that were at the forum that day as everyone was educated and careing about Ibogaine I would trust any of them.

Thank you,


Ibogaine expense

Ibogaine is easily available online at about $40 for two grams, which is approximately two doses. One can safely use psychoactive plants like iboga by using caution: take a small amount at first, perhaps 1/4 gram, and gradually build-up the dose until you feel comfortable taking a whole gram. As someone who has been an addict most of their life, and who has been on methadone maintenance for almost 20 years, Ibogaine is a chance to cure my metabolic disorder of addiction holistically. Methadone is an allopathic remedy, which means it treats the symptoms instead of the cause. Ibogaine treats the root-cause of the metabolic disorder 'disease' of addiction, and it CAN be a cure! Being cured in the case of addiction, means you no longer need opioids anymore, because your brain can once again produce its own endorphins. It's a miracle to anybody dependent on opioids. I find cannabis to be a far superior medicine for treating chronic pain than opioid-type drugs. Many medical marijuana patients, who are primarily using it for chronic pain, are either quitting or drastically reducing their opioid intake. If Ibogaine can cure me, it can cure anybody.

NE SSDP Conference 4/3-4/5

The conference has moved to Boston University!

Hope to see you there,

Irina Alexander
Vice Pres, Univ of MD SSDP

"crack heroin"

First I want to thank Dana Beal and Kevin Franciotti for their wonderful help.

On Monday, I spoke about 'crack heroin' - not "crack and heroin" as stated in the above article. Crack heroin is created by processing heroin with lidocaine, procaine, and other nitrogen carrying chemicals. A senior Harvard scientist estimated only ~5% of the morphine molecule was changed in a two-step reaction, but this ~5% is a much more deadly drug than heroin.

Crack heroin is called "P-Dope" in New Haven and "P-Funk" (for those who know) in New York City. The National AIDS Brigade (NAB) gave it the universal name of "crack heroin."

Like crack cocaine, crack heroin users can't get enough. The high is much shorter than traditional heroin. Crack heroin creates a quicker habit, a stronger habit, more severe withdrawal symptoms, more needle sharing, more HIV/Hepatitis and more deaths.

We've analyzed heroin samples wiith 1000X more lidocaine and prociane than other heroin samples. We've also witnessed deaths from large amounts of lidocaine and procaine. As one person described, "It's the worst thing you'd ever see." Basically, the lidocaine affects the heart, causing convulsions that squeeze out your juices (bile, piss, puke, etc.). NAB warns addicts to try a little before doing a lot. If getting bad "pins and needles" or the shakes, there's too much lidocaine.

In 1978, crack heroin first appeared in New York City. HIV infection among New York City addicts was virtually zero in 1978. 29% in 1979, 44% in 1980, and 52% in 1981. Today, crack heroin has replaced tradition heroin on the East Coast.

In 1980, I entered the Yale School of Medicine and discoved crack heroin replaced tradional heroin in New Haven. Two years later, I enrolled in the Yale School of Public Health. 191 New Haven addicts were interviewed for my MPH thesis and not one reported heroin as a main injection. Instead, they injected crack heroin (P-Dope).

In 1986, NAB established the nation's first needle exchange programs in response to crack heroin. In 1992, NAB obtained heroin samples from Boston, New Haven and New York City. In 1996 and 1998, we again obtained heroin samples from Boston, New Haven and New York City. In 1999, we obtained heroin samples from Boston, New Haven, New York City and Philadelphia. In 2003, we obtained heroin samples from Maine to Florida. Heroin samples not containing lidocaine or procaine (very few) contained other chemicals. The scientist undertaking the analysis stated, "You could write a thesis on those samples."

In 1997, I was intentionally arrested in New Haven with crack heroin. The chief probation officer (retired homocide detective) slammed his desk, exclaiming, "Somebody had to do this!" The prosecutor remarked, "Everybody knows but nobody cares."

That case was dismissed. In 2000 and 2001, I was intentionally arrested 6 times in New York City with crack heroin. Heroin samples from three of the cases were obtained from police for independent analysis. Since 1992, NAB analyzed 12 New York City heroin samples. All samples revealed lidocaine, procaine, or both. The heroin samples obtained from my arrests for independent analysis revealed no lidocaine or procaine. The six cases were dismissed.

The walls of our New Haven drop-in center contained over 130 names of dead AIDS Brigade volunteers. All were black, all were from one neighborhhod, and all injected crack heroin.

Although blacks comprise only 13% of our nation's population, they comprise 57% of IV-drug users with AIDS. More than 30% of IV-drug users with AIDS are brown.

America's number of drug offender arrests has helped produce the world's highest incareration rate. Since 1980, the number of drug prisoners has increased seven fold.

Why hasn't crack heroin been exposed? Methadone is the main stay of drug treatment being offered to opiate addicts. Crack heroin cuts though methadone, making it obsolete as an opiate blocker. Exposing crack heroin would demand the government provide more effective drug education and drug treatment. That's why Ibogaine is so IMPORTANT!

The mentioned lawsuit only contains "crack heroin" in the appendix. But it gives specifics on how lidocaine, procaine, and other NH3 carrying molecules can change the morphine molecule.

The government filed a Motion To Dismiss my lawsuit. The Motion hearing is being held at the BU Law School (2pm/6th floor) on April 1st. Your presence would be greatly appreciated. Judge Young, Harvard Law School graduate and previous chief justice of the Boston U.S. District Court, is holding the Motion hearing. The hearing is being held at a law school because of it's importance (and for law students).

With the help of BU's SSDP President (Stacy), I'll be able to travel from Australia to attend the Motion hearing and to speak at your April 3-5th conference.

I look forward to meeting many like-minded activists.

Sincerely, Jon Stuen-Parker MPH

PS More recently, I was charged with heroin possession in Boston. As with the other cases, NAB hoped using the necessity defense at trial to place crack heroin information on public record. This case was also dismissed.

Robin here Sayin' "right on Parker!"

Jon Parker is a real patriot!Love you forever,and good and improved health to all,long live Walter,and the rest!!!


I am new in the city of boston and I was wondering if there is a shaman for iboga here????

I am really curious...


Great to see progress for ibogaine

Ibogaine is probably the best thing to happen in the past 40 years for drug addicts wanting to break free.  And, it's great to see things like the Boston Ibogaine Forum taking place; so much valuable information being made available; and, its existence shows how awareness and acceptance have grown and continue to grow. Drug addiction is a huge problem, world-wide, and that is not going to change regardless of the legal status of the substances themselves. While countless millions of dollars could be spent in an effort change ibogaine's status in the US, it's not likely to result in a change, for many things work against the legalization of ibogaine in the US especially the mindset of policy makers there especially as it regards drugs like ibogaine. The good news is that safe and professional clinics in Canada, Mexico, and elsewhere, staffed by medical doctors, are ready to help addicts now in their battle to become free. 

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <i> <blockquote> <p> <address> <pre> <h1> <h2> <h3> <h4> <h5> <h6> <br> <b>

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School